Literature DB >> 16633488

Premorbid characterization in schizophrenia: the Pittsburgh High Risk Study.

Matcheri S Keshavan1, Vaibhav A Diwadkar, Debra M Montrose, Jeff A Stanley, Jay W Pettegrew.   

Abstract

Prospective studies of young relatives at risk for schizophrenia can shed light on the possible premorbid precursors of the disease. Ongoing studies in Pittsburgh suggest that young non-psychotic high risk relatives have neurobehavioral, brain structural, physiological, and neurochemical deficits that may date back to childhood or earlier. We summarize these data, review the relevant literature in this emerging field, and provide some new data suggesting alterations in sleep architecture in young relatives at risk for schizophrenia. Collectively, such data are likely to help us to predict the eventual emergence of schizophrenia, schizophrenia spectrum or non-spectrum psychopathology.

Entities:  

Year:  2004        PMID: 16633488      PMCID: PMC1414704     

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   49.548


  44 in total

1.  Hierarchy and heritability: the role of diagnosis and modeling in psychiatric genetics.

Authors:  Kenneth S Kendler
Journal:  Am J Psychiatry       Date:  2002-04       Impact factor: 18.112

2.  Adult third ventricle width and infant behavioral arousal in groups at high and low risk for schizophrenia.

Authors:  K L Dykes; S A Mednick; R A Machon; J Praestholm; J Parnas
Journal:  Schizophr Res       Date:  1992-04       Impact factor: 4.939

3.  Psychosis proneness and ADHD in young relatives of schizophrenia patients.

Authors:  Matcheri S Keshavan; Mandayam Sujata; Akhil Mehra; Debra M Montrose; John A Sweeney
Journal:  Schizophr Res       Date:  2003-01-01       Impact factor: 4.939

4.  Delta sleep deficits in schizophrenia: evidence from automated analyses of sleep data.

Authors:  M S Keshavan; C F Reynolds; M J Miewald; D M Montrose; J A Sweeney; R C Vasko; D J Kupfer
Journal:  Arch Gen Psychiatry       Date:  1998-05

5.  The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia.

Authors:  R W Buchanan; D W Heinrichs
Journal:  Psychiatry Res       Date:  1989-03       Impact factor: 3.222

Review 6.  Electroencephalographic sleep in schizophrenia: a critical review.

Authors:  M S Keshavan; C F Reynolds; D J Kupfer
Journal:  Compr Psychiatry       Date:  1990 Jan-Feb       Impact factor: 3.735

7.  Body-image aberration in Schizophrenia.

Authors:  L J Chapman; J P Chapman; M L Raulin
Journal:  J Abnorm Psychol       Date:  1978-08

8.  Human slow-wave sleep and the cerebral cortex.

Authors: 
Journal:  J Sleep Res       Date:  1992-06       Impact factor: 3.981

Review 9.  Genes for schizophrenia? Recent findings and their pathophysiological implications.

Authors:  Paul J Harrison; Michael J Owen
Journal:  Lancet       Date:  2003-02-01       Impact factor: 79.321

10.  Social anhedonia as a predictor of the development of schizophrenia-spectrum disorders.

Authors:  T R Kwapil
Journal:  J Abnorm Psychol       Date:  1998-11
View more
  38 in total

Review 1.  Psychosis prediction and clinical utility in familial high-risk studies: selective review, synthesis, and implications for early detection and intervention.

Authors:  Jai L Shah; Neeraj Tandon; Matcheri S Keshavan
Journal:  Early Interv Psychiatry       Date:  2013-05-22       Impact factor: 2.732

Review 2.  Comorbid Insomnia and Psychiatric Disorders: An Update.

Authors:  Khurshid A Khurshid
Journal:  Innov Clin Neurosci       Date:  2018-04-01

3.  Adolescents at clinical-high risk for psychosis: Circadian rhythm disturbances predict worsened prognosis at 1-year follow-up.

Authors:  Jessica R Lunsford-Avery; Bruno da Silva Brandão Gonçalves; Elisa Brietzke; Rodrigo A Bressan; Ary Gadelha; Randy P Auerbach; Vijay A Mittal
Journal:  Schizophr Res       Date:  2017-02-04       Impact factor: 4.939

4.  Actigraphic-measured sleep disturbance predicts increased positive symptoms in adolescents at ultra high-risk for psychosis: A longitudinal study.

Authors:  Jessica R Lunsford-Avery; Monique K LeBourgeois; Tina Gupta; Vijay A Mittal
Journal:  Schizophr Res       Date:  2015-03-26       Impact factor: 4.939

5.  Psychotic disorders in children and adolescents: a primer on contemporary evaluation and management.

Authors:  Jonathan R Stevens; Jefferson B Prince; Laura M Prager; Theodore A Stern
Journal:  Prim Care Companion CNS Disord       Date:  2014-03-13

6.  Biomarkers and clinical staging in psychiatry.

Authors:  Patrick McGorry; Matcheri Keshavan; Sherilyn Goldstone; Paul Amminger; Kelly Allott; Michael Berk; Suzie Lavoie; Christos Pantelis; Alison Yung; Stephen Wood; Ian Hickie
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

7.  Sleep dysfunction and thalamic abnormalities in adolescents at ultra high-risk for psychosis.

Authors:  Jessica R Lunsford-Avery; Joseph M Orr; Tina Gupta; Andrea Pelletier-Baldelli; Derek J Dean; Ashley K Smith Watts; Jessica Bernard; Zachary B Millman; Vijay A Mittal
Journal:  Schizophr Res       Date:  2013-10-04       Impact factor: 4.939

8.  Evidence of gray matter reduction and dysfunction in chromosome 22q11.2 deletion syndrome.

Authors:  Vandana Shashi; Thomas R Kwapil; Jessica Kaczorowski; Margaret N Berry; Cesar S Santos; Timothy D Howard; Dhruman Goradia; Konasale Prasad; Diwadkar Vaibhav; Rajaprabhakaran Rajarethinam; Edward Spence; Matcheri S Keshavan
Journal:  Psychiatry Res       Date:  2010-01-30       Impact factor: 3.222

9.  Premorbid cognitive deficits in young relatives of schizophrenia patients.

Authors:  Matcheri S Keshavan; Shreedhar Kulkarni; Tejas Bhojraj; Alan Francis; Vaibhav Diwadkar; Debra M Montrose; Larry J Seidman; John Sweeney
Journal:  Front Hum Neurosci       Date:  2010-03-09       Impact factor: 3.169

10.  Does abnormal sleep impair memory consolidation in schizophrenia?

Authors:  Dara S Manoach; Robert Stickgold
Journal:  Front Hum Neurosci       Date:  2009-09-01       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.